The population of survivors following diagnosis and treatment for medulloblastoma is thankfully on the rise. An increased focus on the quality of that survivorship has expanded the concept of cure to include efforts aimed at improving long-term cognitive outcome. It is well established in the literature that decline in overall intellect and academic performance is experienced by a majority of those undergoing treatment for pediatric medulloblastoma. This decline is believed to be secondary to decline in core cognitive abilities, which in turn are related to underlying damage to neuroanatomical substrates. A review of research on neurodevelopmental impacts following diagnosis and treatment for pediatric medulloblastoma is presented. Particular consideration is given to studies recently published that also reflect critical collaboration among those within the fields of neuropsychology and neuro-imaging. Results from the review are combined within a conceptual model upon which to guide future research and clinical efforts. Keywords medulloblastoma; cognitive deficits; brain tumor; model; processing speed; attention; working memory Callouts 1. Based on the knowledge derived from studies of long term outcomes, it is important to consider medulloblastoma, as well as other pediatric cancers, as a condition resulting in life long morbidities related to the treatment for, but separate from, the primary presenting disease.
2.Intellectual and academic outcomes are considered distal markers and secondary to changes in underlying core cognitive skills.3. While much of the research to date has focused on risk for deficits in cognitive function, attention should also be paid to resilience.
4.Consideration of the current literature on children diagnosed and treated for medulloblastoma reveals there is at least the start of a conceptual model illustrating the likely relationships between treatment, underlying